Central Oregon Pathology Consultants has been in business for nearly 60 years, offering molecular testing and other diagnostic services east of the Cascade Range.
Sep 23, 2024
0
0
Children who are injured by firearms require significantly more inpatient care, have higher medical complication rates and face a greater risk of death than children with other forms of trauma, according to research presented ...
11 hours ago
0
0
For the over 1 million Americans who survive severe traumatic brain injuries each year, the road to recovery is often long and challenging. Disruption of the autonomic nervous system, which controls involuntary functions ...
Sep 24, 2024
0
0
Controversial fentanyl lollipops and similar products will no longer be made by drug makers, the U.S. Food and Drug Administration has announced.
Sep 20, 2024
0
0
Remote video consultations between patients and mental health specialists show a small but significant improvement in symptoms of depression and anxiety, finds a trial published by The BMJ.
Sep 25, 2024
0
16
Research at UMC Utrecht has identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections. Using genetic and functional approaches, the researchers also managed ...
Sep 26, 2024
0
25
California, the epicenter of the U.S. homelessness crisis, is cracking down on people living outside like never before, taking an aggressive new stance to dismantling and clearing homeless encampments in the wake of a watershed ...
Sep 23, 2024
1
0
Pharmacists now have more guidance for combating the opioid crisis and providing treatment to patients, thanks to new national guidelines developed at the University of Houston College of Pharmacy. The Pharmacy Access to ...
Sep 24, 2024
0
1
Infants who were exclusively fed breast milk during their hospitalization at birth were 22% less likely to develop asthma in early childhood, according to research presented during the American Academy of Pediatrics 2024 ...
11 hours ago
0
0
Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown that the commonly used high-cholesterol drug simvastatin cannot slow disability progression.
Sep 24, 2024
0
0
